Press release
RNA Based Therapeutics Market 2023 - 2030 an overview, benefits and prospectus with growing at a CAGR of 17.6% - Says Allied Market Research
According to the report, the global RNA based therapeutics industry was estimated at $4.93 billion in 2021, and is anticipated to hit $25.12 billion by 2030.
CAGR: 17.6%
Current Market Size: USD 4.93 Billion
Forecast Growing Region: APAC
Largest Market: North America
Projection Time: 2021- 2030
Base Year: 2020
Report Key Pointer: COVID-19 Outbreak & Impact
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/546
What are the benefits of RNA therapeutics?
However, RNA-based treatments may have therapeutic potential for diseases, such as diabetes, cancer, and Huntington's disease [2,10,11,12,13]. RNA therapies may provide better treatment options to target the pathophysiological mechanisms of these disorders, which may lead to better outcomes for patients.
Ascend in drives from government for enormous scope sequencing projects drives the development of the worldwide RNA based therapeutics market. Then again, obstacles in drug conveyance, significant expense of exploration, and dangers of disappointment control the development somewhat. In any case, early commercialization of pipeline therapeutics is supposed to set out worthwhile open doors in the business.
Impact of COVID-19 on RNA Based Therapeutics Market-
Also, mRNA vaccines could potentially offer long-term solutions all over the world for diseases ranging from influenza to AIDS, but owing to lockdown measures and temporary closure of research institutes and academic research, the demand for RNA based therapeutic solutions decreased significantly.
This trend is quite likely to continue till the pandemic is completely over.
Get detailed COVID-19 impact analysis on the RNA Based Therapeutic Market- https://www.alliedmarketresearch.com/request-for-customization/546?reqfor=covid
Key players in the industry-
Silence Therapeutics plc.
Arbutus Biopharma Corporation
Ionis Pharmaceuticals
Sarepta Therapeutics
Alnylam Pharmaceuticals, Inc.
Benitec Biopharma Inc.
Genzyme (Sanofi), Arrowhead Pharmaceuticals
Biogen, Inc.
Gradalis, Inc.
By Regional Analysis:
By region, the market across North America dominated in 2020, garnering more than two-fifths the global RNA based therapeutics market. High expenditure on R&D, presence of major players & their product availability, and well-established healthcare infrastructure in the region propel the market growth. Simultaneously, the Asia-Pacific region is also expected to cite the fastest CAGR of 18.9% throughout the forecast period. This is attributed to improvements in R&D facilities, available disposable income, and rapidly developing economic conditions.
North America (U.S., Canada, Mexico)
Europe (Germany, France, United Kingdom, Rest of Europe)
Asia-Pacific (Japan, China, Australia, India, Rest of Asia-Pacific)
LAMEA (Latin America, Middle East, Africa)
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/546
Trending Reports in Healthcare Industry:
Ophthalmic Devices Market https://www.alliedmarketresearch.com/ophthalmic-devices-market
Tablet Coatings Market https://www.alliedmarketresearch.com/tablet-coatings-market-A11539
Biosimilars Market https://www.alliedmarketresearch.com/global-biosimilars-market
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA Based Therapeutics Market 2023 - 2030 an overview, benefits and prospectus with growing at a CAGR of 17.6% - Says Allied Market Research here
News-ID: 2908393 • Views: …
More Releases from Allied Market Research
Dry Natural Gas Market Is Set to Garner Staggering Revenues By 2031
Increased innovation in natural gas drying equipment is a key market trend that offers opportunities for prominent players in the forecast period. Dry natural gas is preferable for environmental and public health. The use of natural gas as energy resource in power generation systems is anticipated to drive power generation system. The increased environmental concerns, increased government initiatives for the construction of dry gas processing infrastructure, expensive initial infrastructure investment,…
Robotics Market is Growing At A CAGR of 27.7% from 2021 to 2030 | Latest Researc …
According to a new report published by Allied Market Research, titled,the global robotics market size was valued at $12.1 billion in 2020, and is expected to reach $149.9 billion by 2030, with a CAGR of 27.7% from 2021 to 2030.
In 2020, Europe dominated the global robotics market, in terms of revenue, accounting for around 44.4% share of the global market. The scope of the market limits to the study…
Clean Hydrogen Market to Witness Comprehensive Growth by 2032
Clean hydrogen is the form of hydrogen that is produced through processes that result in lower carbon emissions (through carbon capture, storage, and utilization (CCUS)) or zero carbon emissions. Climate change and net-zero commitments are major reasons for the shift from fossil fuels to alternatives such as synthetic fuels, renewables, nuclear fusion energy, clean hydrogen, and others. Several advanced hydrogen technologies are being developed and countries are positioning themselves to…
Crash Barrier Systems Market 2021 to 2030: Growth Statistics, Facts and Regional …
According to a new report published by Allied Market Research, titled, , the global Crash Barrier Systems industry generated $7.8 billion in 2020, and is anticipated to generate $11.7 billion by 2030, witnessing a CAGR of 4.2% from 2021 to 2030.
Prime determinants of growth
Expansion of infrastructure, increase in road safety awareness, and growth in the automotive industry drive the growth of the global crash barrier systems market. However, high severity…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
